Department of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.
Int J Health Policy Manag. 2021 Nov 1;10(11):673-677. doi: 10.34172/ijhpm.2020.244.
The World Health Organization's (WHO's) Choosing Interventions that are Cost-Effective (CHOICE) programme has been a global leader in the field of economic evaluation, specifically cost-effectiveness analysis for almost 20 years. WHO-CHOICE takes a "generalized" approach to cost-effectiveness analysis that can be seen as a quantitative assessment of current and future efficiency within a health system. This supports priority setting processes, ensuring that health stewards know how to spend resources in order to achieve the highest health gain as one consideration in strategic planning. This approach is unique in the global health landscape. This paper provides an overview of the methodological approach, updates to analytic framework over the past 10 years, and the added value of the WHO-CHOICE approach in supporting decision makers as they aim to use limited health resources to achieve the Sustainable Development Goals (SDGs) by 2030.
世界卫生组织（WHO）的“选择具有成本效益的干预措施（CHOICE）”项目在经济评估领域，特别是成本效益分析方面，已经引领全球近 20 年。WHO-CHOICE 采用了一种“广义”的成本效益分析方法，可以看作是对卫生系统内当前和未来效率的一种量化评估。这支持了优先事项设定过程，确保卫生管理者知道如何花费资源以实现最高的健康收益，作为战略规划中的一个考虑因素。这种方法在全球卫生领域是独特的。本文概述了方法学方法，以及过去 10 年分析框架的更新，以及 WHO-CHOICE 方法在支持决策者方面的附加价值，因为他们旨在利用有限的卫生资源来实现 2030 年可持续发展目标（SDGs）。
